The Wall Street Journal has an article focusing on Andrew von Eschenbach, commissioner of the US Food and Drug Administration. Critics have charged that the FDA can't manage regulations of everything it's supposed to be regulating, and now von Eschenbach responds that "the agency needs more money than the Bush administration has proposed, and it requires a revamped organization to better oversee drug safety and other issues," according to the article.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.